Steward Partners Investment Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $442K | Buy |
1,357
+295
| +28% | +$96.2K | ﹤0.01% | 1357 |
|
|
2025
Q1 | $287K | Buy |
1,062
+122
| +13% | +$32.9K | ﹤0.01% | 1470 |
|
|
2024
Q4 | $221K | Buy |
940
+40
| +4% | +$9.41K | ﹤0.01% | 1553 |
|
|
2024
Q3 | $248K | Buy |
900
+10
| +1% | +$2.75K | ﹤0.01% | 1419 |
|
|
2024
Q2 | $216K | Buy |
890
+175
| +24% | +$42.5K | ﹤0.01% | 1409 |
|
|
2024
Q1 | $107K | Buy |
715
+235
| +49% | +$35.1K | ﹤0.01% | 1732 |
|
|
2023
Q4 | $91.9K | Buy |
480
+60
| +14% | +$11.5K | ﹤0.01% | 1733 |
|
|
2023
Q3 | $74.4K | Buy |
420
+15
| +4% | +$2.66K | ﹤0.01% | 1721 |
|
|
2023
Q2 | $76.9K | Hold |
405
| – | – | ﹤0.01% | 1702 |
|
|
2023
Q1 | $81.1K | Sell |
405
-18
| -4% | -$3.61K | ﹤0.01% | 1665 |
|
|
2022
Q4 | $101K | Buy |
423
+18
| +4% | +$4.28K | ﹤0.01% | 1548 |
|
|
2022
Q3 | $81K | Sell |
405
-50
| -11% | -$10K | ﹤0.01% | 1574 |
|
|
2022
Q2 | $66K | Sell |
455
-8
| -2% | -$1.16K | ﹤0.01% | 1667 |
|
|
2022
Q1 | $76K | Sell |
463
-291
| -39% | -$47.8K | ﹤0.01% | 1709 |
|
|
2021
Q4 | $128K | Hold |
754
| – | – | ﹤0.01% | 1485 |
|
|
2021
Q3 | $142K | Hold |
754
| – | – | ﹤0.01% | 1416 |
|
|
2021
Q2 | $128K | Sell |
754
-2,521
| -77% | -$428K | ﹤0.01% | 1917 |
|
|
2021
Q1 | $462K | Buy |
3,275
+2,521
| +334% | +$356K | 0.01% | 920 |
|
|
2020
Q4 | $98K | Sell |
754
-120
| -14% | -$15.6K | ﹤0.01% | 1366 |
|
|
2020
Q3 | $127K | Hold |
874
| – | – | ﹤0.01% | 1124 |
|
|
2020
Q2 | $129K | Buy |
874
+24
| +3% | +$3.54K | ﹤0.01% | 1038 |
|
|
2020
Q1 | $92K | Sell |
850
-295
| -26% | -$31.9K | ﹤0.01% | 1021 |
|
|
2019
Q4 | $131K | Hold |
1,145
| – | – | ﹤0.01% | 1019 |
|
|
2019
Q3 | $92K | Hold |
1,145
| – | – | ﹤0.01% | 1116 |
|
|
2019
Q2 | $83K | Buy |
+1,145
| New | +$83K | ﹤0.01% | 1125 |
|
|
2018
Q4 | – | Sell |
-970
| Closed | -$85K | – | 823 |
|
|
2018
Q3 | $85K | Buy |
970
+100
| +11% | +$8.76K | ﹤0.01% | 982 |
|
|
2018
Q2 | $86K | Sell |
870
-355
| -29% | -$35.1K | 0.01% | 891 |
|
|
2018
Q1 | $145K | Buy |
+1,225
| New | +$145K | 0.01% | 687 |
|